Seroba Life Sciences Daniel O’Mahony is a Partner at Seroba Life Sciences venture capital fund and brings a wealth of experience from pharma and medtech industry in product development, strategic planning, licensing, corporate venturing, technology commercialisation and venture capital investment. Daniel graduated with a Ph.D. from University College Cork, holds a business degree in technology management from the Smurfit Business School and has held academic appointments in Ireland and USA. He currently sits on a number of boards include Atlantic Therapeutics and ATXA Therapeutics. He previously sat on the boards of PQ Bypass (acquired by Endologix), Novate Medical (acquired by BTG), Apica Cardiovascular (acquired by Thoratec), Covagen (acquired by Janssen), Stokes Bio (acquired by Life Technologies), Straatum (acquired by Lam Research Corporation).
December 3rd & 4th, 2024
IN-PERSON | LILLE, FR
December 11th & 12th, 2024
DIGITAL MEETINGS
MedFIT is your unique opportunity to connect with international key innovators in the MedTech, diagnostic and digital health sectors. As a leading European partnering event, MedFIT provides the ideal environment to build partnerships for all public and private actors, to source innovative and competitive early-stage R&D projects, to speed the emergence of collaborative projects, to increase licensing opportunities, to obtain funding and to facilitate market access.
Learn more
Organised by:
With the support of:
INSTITUTIONAL PARTNERS
"*" indicates required fields
Lille Grand Palais
1, Boulevard des Cités Unies
59777 Lille, FRANCE
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WARNING: Some fraudulent companies are supposedly providing the attendees list of MedFIT. And some are passing themselves off as being MedFIT organisation members and asking you to pay. Please note that the MedFIT team will never sell you the MedFIT attendees list and never ask for your bank account details to make you pay for hotel bookings, exhibition fees or others, and certainly not over the phone.Please be extremely vigilant.